… risk analysis systems for evaluating clinical outcome for patients with myelodysplastic syndrome
(… To attempt to improve on these systems, an International MDS Risk Analysis Workshop …

… scoring systems without karyotype for predicting survival in patients with myelodysplastic
syndromes. … with karyotype for predicting outcome in patients with myelodysplastic syndromes. …

… The International Prognostic Scoring Sytem (IPSS) is an important standard for ssessing
prognosis of primary untreated adult patients with myelodysplastic syndromes (MDS). To refine …

… Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS)
are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers …

Myelodysplastic syndromes are clonal marrow stem-cell disorders, characterised by
ineffective haemopoiesis leading to blood cytopenias, and by progression to acute myeloid …

… They have been classified according to the FAB criteria and we have devised a simple
scoring system based on the presentation blood and bone marrow aspirate findings. This system …

… Myelodysplastic syndromes are treated on an individualized, risk… The myelodysplastic
syndromes (MDS) are among the … and new prognostic scoring systems have been developed. In …

A risk-adapted treatment strategy is mandatory for myelodysplastic syndromes (MDS). We
refined the World Health Organization (WHO)-classification-based Prognostic Scoring System (…

… myelodysplastic syndrome has been reviewed and the survival updated. A scoring system is
… Both the criteria for the FAB subtypes and the scoring system can be applied easily in each …

… myelodysplastic syndromes (MDSs). The most commonly used prognostic classification system
is the International Prognostic Scoring System (… -based prognostic scoring system (WPSS)…